Development of an optimized activatable MMP-14 targeted SPECT imaging probe

Gregory A. Watkins, Ella Fung Jones, M. Scott Shell, Henry F. VanBrocklin, Mei Hsiu Pan, Stephen M. Hanrahan, Jin Jin Feng, Jiang He, Nor Eddine Sounni, Ken A. Dill, Christopher H. Contag, Lisa Coussens, Benjamin L. Franc

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a membrane-associated protease implicated in a variety of tissue remodeling processes and a molecular hallmark of select metastatic cancers. The ability to detect MMP-14 in vivo would be useful in studying its role in pathologic processes and may potentially serve as a guide for the development of targeted molecular therapies. Four MMP-14 specific probes containing a positively charged cell penetrating peptide (CPP) d-arginine octamer (r8) linked with a MMP-14 peptide substrate and attenuating sequences with glutamate (8e, 4e) or glutamate-glycine (4eg and 4egg) repeating units were modeled using an AMBER force field method. The probe with 4egg attenuating sequence exhibited the highest CPP/attenuator interaction, predicting minimized cellular uptake until cleaved. The in vitro MMP-14-mediated cleavage studies using the human recombinant MMP-14 catalytic domain revealed an enhanced cleavage rate that directly correlated with the linearity of the embedded peptide substrate sequence. Successful cleavage and uptake of a technetium-99m labeled version of the optimal probe was demonstrated in MMP-14 transfected human breast cancer cells. Two-fold reduction of cellular uptake was found in the presence of a broad spectrum MMP inhibitor. The combination of computational chemistry, parallel synthesis and biochemical screening, therefore, shows promise as a set of tools for developing new radiolabeled probes that are sensitive to protease activity.

Original languageEnglish (US)
Pages (from-to)653-659
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume17
Issue number2
DOIs
StatePublished - Jan 15 2009
Externally publishedYes

Fingerprint

Single-Photon Emission-Computed Tomography
Matrix Metalloproteinases
Imaging techniques
Cell-Penetrating Peptides
Matrix Metalloproteinase 14
Glutamic Acid
Peptide Hydrolases
Molecular Targeted Therapy
Computational chemistry
Peptides
Matrix Metalloproteinase Inhibitors
Technetium
Pathologic Processes
Substrates
Glycine
Arginine
Catalytic Domain
Screening
Cells
Tissue

Keywords

  • Cancer
  • MMP-14
  • Protease sensitive probe
  • SPECT imaging

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Watkins, G. A., Jones, E. F., Scott Shell, M., VanBrocklin, H. F., Pan, M. H., Hanrahan, S. M., ... Franc, B. L. (2009). Development of an optimized activatable MMP-14 targeted SPECT imaging probe. Bioorganic and Medicinal Chemistry, 17(2), 653-659. https://doi.org/10.1016/j.bmc.2008.11.078

Development of an optimized activatable MMP-14 targeted SPECT imaging probe. / Watkins, Gregory A.; Jones, Ella Fung; Scott Shell, M.; VanBrocklin, Henry F.; Pan, Mei Hsiu; Hanrahan, Stephen M.; Feng, Jin Jin; He, Jiang; Sounni, Nor Eddine; Dill, Ken A.; Contag, Christopher H.; Coussens, Lisa; Franc, Benjamin L.

In: Bioorganic and Medicinal Chemistry, Vol. 17, No. 2, 15.01.2009, p. 653-659.

Research output: Contribution to journalArticle

Watkins, GA, Jones, EF, Scott Shell, M, VanBrocklin, HF, Pan, MH, Hanrahan, SM, Feng, JJ, He, J, Sounni, NE, Dill, KA, Contag, CH, Coussens, L & Franc, BL 2009, 'Development of an optimized activatable MMP-14 targeted SPECT imaging probe', Bioorganic and Medicinal Chemistry, vol. 17, no. 2, pp. 653-659. https://doi.org/10.1016/j.bmc.2008.11.078
Watkins GA, Jones EF, Scott Shell M, VanBrocklin HF, Pan MH, Hanrahan SM et al. Development of an optimized activatable MMP-14 targeted SPECT imaging probe. Bioorganic and Medicinal Chemistry. 2009 Jan 15;17(2):653-659. https://doi.org/10.1016/j.bmc.2008.11.078
Watkins, Gregory A. ; Jones, Ella Fung ; Scott Shell, M. ; VanBrocklin, Henry F. ; Pan, Mei Hsiu ; Hanrahan, Stephen M. ; Feng, Jin Jin ; He, Jiang ; Sounni, Nor Eddine ; Dill, Ken A. ; Contag, Christopher H. ; Coussens, Lisa ; Franc, Benjamin L. / Development of an optimized activatable MMP-14 targeted SPECT imaging probe. In: Bioorganic and Medicinal Chemistry. 2009 ; Vol. 17, No. 2. pp. 653-659.
@article{9dd60386deb54bf6aa10388eeea4f7aa,
title = "Development of an optimized activatable MMP-14 targeted SPECT imaging probe",
abstract = "Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a membrane-associated protease implicated in a variety of tissue remodeling processes and a molecular hallmark of select metastatic cancers. The ability to detect MMP-14 in vivo would be useful in studying its role in pathologic processes and may potentially serve as a guide for the development of targeted molecular therapies. Four MMP-14 specific probes containing a positively charged cell penetrating peptide (CPP) d-arginine octamer (r8) linked with a MMP-14 peptide substrate and attenuating sequences with glutamate (8e, 4e) or glutamate-glycine (4eg and 4egg) repeating units were modeled using an AMBER force field method. The probe with 4egg attenuating sequence exhibited the highest CPP/attenuator interaction, predicting minimized cellular uptake until cleaved. The in vitro MMP-14-mediated cleavage studies using the human recombinant MMP-14 catalytic domain revealed an enhanced cleavage rate that directly correlated with the linearity of the embedded peptide substrate sequence. Successful cleavage and uptake of a technetium-99m labeled version of the optimal probe was demonstrated in MMP-14 transfected human breast cancer cells. Two-fold reduction of cellular uptake was found in the presence of a broad spectrum MMP inhibitor. The combination of computational chemistry, parallel synthesis and biochemical screening, therefore, shows promise as a set of tools for developing new radiolabeled probes that are sensitive to protease activity.",
keywords = "Cancer, MMP-14, Protease sensitive probe, SPECT imaging",
author = "Watkins, {Gregory A.} and Jones, {Ella Fung} and {Scott Shell}, M. and VanBrocklin, {Henry F.} and Pan, {Mei Hsiu} and Hanrahan, {Stephen M.} and Feng, {Jin Jin} and Jiang He and Sounni, {Nor Eddine} and Dill, {Ken A.} and Contag, {Christopher H.} and Lisa Coussens and Franc, {Benjamin L.}",
year = "2009",
month = "1",
day = "15",
doi = "10.1016/j.bmc.2008.11.078",
language = "English (US)",
volume = "17",
pages = "653--659",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Development of an optimized activatable MMP-14 targeted SPECT imaging probe

AU - Watkins, Gregory A.

AU - Jones, Ella Fung

AU - Scott Shell, M.

AU - VanBrocklin, Henry F.

AU - Pan, Mei Hsiu

AU - Hanrahan, Stephen M.

AU - Feng, Jin Jin

AU - He, Jiang

AU - Sounni, Nor Eddine

AU - Dill, Ken A.

AU - Contag, Christopher H.

AU - Coussens, Lisa

AU - Franc, Benjamin L.

PY - 2009/1/15

Y1 - 2009/1/15

N2 - Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a membrane-associated protease implicated in a variety of tissue remodeling processes and a molecular hallmark of select metastatic cancers. The ability to detect MMP-14 in vivo would be useful in studying its role in pathologic processes and may potentially serve as a guide for the development of targeted molecular therapies. Four MMP-14 specific probes containing a positively charged cell penetrating peptide (CPP) d-arginine octamer (r8) linked with a MMP-14 peptide substrate and attenuating sequences with glutamate (8e, 4e) or glutamate-glycine (4eg and 4egg) repeating units were modeled using an AMBER force field method. The probe with 4egg attenuating sequence exhibited the highest CPP/attenuator interaction, predicting minimized cellular uptake until cleaved. The in vitro MMP-14-mediated cleavage studies using the human recombinant MMP-14 catalytic domain revealed an enhanced cleavage rate that directly correlated with the linearity of the embedded peptide substrate sequence. Successful cleavage and uptake of a technetium-99m labeled version of the optimal probe was demonstrated in MMP-14 transfected human breast cancer cells. Two-fold reduction of cellular uptake was found in the presence of a broad spectrum MMP inhibitor. The combination of computational chemistry, parallel synthesis and biochemical screening, therefore, shows promise as a set of tools for developing new radiolabeled probes that are sensitive to protease activity.

AB - Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a membrane-associated protease implicated in a variety of tissue remodeling processes and a molecular hallmark of select metastatic cancers. The ability to detect MMP-14 in vivo would be useful in studying its role in pathologic processes and may potentially serve as a guide for the development of targeted molecular therapies. Four MMP-14 specific probes containing a positively charged cell penetrating peptide (CPP) d-arginine octamer (r8) linked with a MMP-14 peptide substrate and attenuating sequences with glutamate (8e, 4e) or glutamate-glycine (4eg and 4egg) repeating units were modeled using an AMBER force field method. The probe with 4egg attenuating sequence exhibited the highest CPP/attenuator interaction, predicting minimized cellular uptake until cleaved. The in vitro MMP-14-mediated cleavage studies using the human recombinant MMP-14 catalytic domain revealed an enhanced cleavage rate that directly correlated with the linearity of the embedded peptide substrate sequence. Successful cleavage and uptake of a technetium-99m labeled version of the optimal probe was demonstrated in MMP-14 transfected human breast cancer cells. Two-fold reduction of cellular uptake was found in the presence of a broad spectrum MMP inhibitor. The combination of computational chemistry, parallel synthesis and biochemical screening, therefore, shows promise as a set of tools for developing new radiolabeled probes that are sensitive to protease activity.

KW - Cancer

KW - MMP-14

KW - Protease sensitive probe

KW - SPECT imaging

UR - http://www.scopus.com/inward/record.url?scp=58549107779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549107779&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2008.11.078

DO - 10.1016/j.bmc.2008.11.078

M3 - Article

VL - 17

SP - 653

EP - 659

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 2

ER -